Description :This seminar is intended to help you adequately implement good social medical practices to avoid FDA enforcement actions for potential misbranding of your drug or device products.The U.S. Food and Drug Administration (FDA) reviewed the firm’s sponsored link on the Google as part of the FDA’s routine monitoring and surveillance program by the Office of Prescription Drug Promotion (OPDP). It is imperative that firms ensure their compliance to the applicable laws and regulations when they provide drug or device information to the public through social media.In this presentation, the speaker will discuss what to say or not to say including how to implement your good social medical practices while ensuring your compliance by avoiding potential FDA enforcement actions.The speaker will present how to implement good social media practices in a CAC-SI manner (CAC-SI refers to current, accurate and complete/comprehensive in a systematic, integrated manner).Through this 60-min presentation, you will have opportunities to bring great value and benefits to your firm’s implementation of good social media practices in an efficient and effective manner.Areas Covered in the Session :Applicable Statute(s) and RegulationsDefinitionsRegulatory RequirementsFDA’s Monitoring and Surveillance ProgramFDA Social Media Guidance DocumentsImplementing Good Social Medical PracticesFDA’s Untitled Letter AnalysisCommon Avoidable MistakesHow to Prevent Common MistakesHow to Avoid FDA’s ActionsPASS-IT GuidesConclusionWho Will Benefit:R&D Scientists, Managers, Directors, and VPsRegulatory Affairs and Compliance ProfessionalsClinical Affairs ProfessionalsQuality ProfessionalsConsultantsLegal and Compliance OfficersMarketing ProfessionalsSenior ManagementAnyone Interested in the Subject